| 发明名称 |
RIBAVIRIN-PEGYLATED INTERFERON ALFA HCV COMBINATION THERAPY |
| 摘要 |
The use of ribavirin and/or pegylated interferon alfa for the preparation of a pharmaceutical composition for the treatment of chronic hepatitis C infection comprising a therapeutically weight-effective amount of ribavirin and a therapeutically effective amount of pegylated, e.g, pegylated interferon-alfa-2b or -2a, is disclosed. |
| 申请公布号 |
WO0232414(A3) |
申请公布日期 |
2003.04.03 |
| 申请号 |
WO2001US32434 |
申请日期 |
2001.10.16 |
| 申请人 |
SCHERING CORPORATION;ALBRECHT, JANICE |
发明人 |
ALBRECHT, JANICE |
| 分类号 |
A61K31/7056;A61K38/21;A61K45/06;A61P1/16;A61P31/12;A61P31/20 |
主分类号 |
A61K31/7056 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
